Vanda Pharmaceuticals (VNDA) Interest & Investment Income (2010 - 2011)

Vanda Pharmaceuticals' (VNDA) quarterly Interest & Investment Income came in at $99000.0 in Q4 2011, down 30.28% year-on-year from $142000.0 in Q4 2010, and down 6.6% quarter-over-quarter from $106000.0 in Q3 2011.

Vanda Pharmaceuticals (VNDA) Interest & Investment Income (2010 - 2011) Analysis & Trends

Vanda Pharmaceuticals has disclosed Interest & Investment Income across 2 years of filings, most recently posting $99000.0 for Q4 2011.

  • Interest & Investment Income for Q4 2011 came in at $99000.0, down 30.28% year-over-year; the trailing twelve-month figure through Dec 2011 was $468000.0 (changed N/A YoY), and the FY2011 annual result was $461000.0, up 6.96% from the prior year.
  • Interest & Investment Income came in at $99000.0 for Q4 2011 at Vanda Pharmaceuticals, down from $106000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $156000.0 in Q3 2010 to a low of $86000.0 in Q2 2010.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 597,319.59
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 40.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 305,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 103,341.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -14.79 Mn
10 Vanda Pharmaceuticals 345.46 Mn 143.15 Mn 48.56 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 99,000.00
Sep 30, 2011 106,000.00
Jun 30, 2011 121,000.00
Dec 31, 2010 142,000.00
Sep 30, 2010 156,000.00
Jun 30, 2010 86,000.00